Aravive, Inc. Gains 31.75%

Fri, Oct 20, 2023 at 07:18 PM
Aravive, Inc. Gains 31.75%

Aravive, Inc. (ARAV:NASDAQ) shot up at $0.19, a gain of 31.7%. On Fri, Oct 20, 2023, ARAV:NASDAQ touched a New 2-Week Intraday High of $0.25. From Fri, Oct 06, 2023, the stock recorded 30.00% Up Days and 45.45% Green Days

The stock spiked on Wed, Oct 18, 2023 at $0.29 with a volume of 43M+.

About Aravive, Inc. (ARAV:NASDAQ)

Versartis Inc is an endocrine-focused biopharmaceutical company initially developing long-acting recombinant human growth hormone for the treatment of growth hormone deficiency.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.